Asensus Surgical is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking the Clinical Intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.Senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: https://www.senhance.com/indications.
| Website | https://asensus.com/ |
| Revenue | $8.7 million |
| Employees | 226 (0 on RocketReach) |
| Founded | 2006 |
| Address | 1 Tw Alexander Dr Suite 160, Durham, North Carolina 27701, US |
| Phone | +1 337-735-9300 |
| Technologies |
JavaScript
,
HTML
,
PHP
+35 more
(view full list)
|
| Keywords | Surgical Robotics, Digital Surgery, Robotic Surgery Systems, Minimally Invasive Surgery, Clinical Intelligence, Surgical Outcomes, Medical Devices, Surgical Technology, Surgical Automation, Computer Assisted Surgery, Surgical Innovation, Precision Surgery, Surgical Instruments, Surgical Workflow, Advanced Surgery, Medical Technology, Healthcare Technology |
| Competitors | Johnson & Johnson, Medtronic, Richard Wolf GmbH, Stryker, Intuitive, Olympus Corporation, Caresyntax, Augmedics, MediSieve, Surgical Innovations +24 more (view full list) |
Looking for a particular Asensus Surgical employee's phone or email?
The Asensus Surgical annual revenue was $8.7 million in 2026.
Asensus Surgical is based in Durham, North Carolina.